Lipidomics studies on macrophages - bone marrow-derived macrophages treated with Kdo2-Lipid A and ATP
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO + ATP | 0.3 | MSG090928944 | 1.58 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO + ATP | 0.5 | MSG090928948 | 2.29 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO + ATP | 1.0 | MSG090928952 | 1.66 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO + ATP | 2.0 | MSG090928956 | 1.14 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO + ATP | 4.0 | MSG090928960 | 1.26 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO + ATP | 8.0 | MSG090928964 | 1.11 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO + ATP | 20.0 | MSG090924938 | 1.41 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO | 0.3 | MSG090928942 | 0.859 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO | 0.5 | MSG090928946 | 1.05 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO | 1.0 | MSG090928950 | 0.844 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO | 2.0 | MSG090928954 | 0.872 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO | 4.0 | MSG090928958 | 1.23 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO | 8.0 | MSG090928962 | 0.756 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | KDO | 20.0 | MSG090928966 | 0.862 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 0.0 | MSG090928940 | 1 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 0.3 | MSG090928941 | 0.635 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 0.5 | MSG090928945 | 0.879 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 1.0 | MSG090928949 | 0.768 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 2.0 | MSG090928953 | 0.96 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 4.0 | MSG090928957 | 0.742 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 8.0 | MSG090928961 | 0.793 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | C | 20.0 | MSG090928965 | 0.919 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | ATP | 0.3 | MSG090928943 | 1.46 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | ATP | 0.5 | MSG090928947 | 1.39 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | ATP | 1.0 | MSG090928951 | 1.14 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | ATP | 2.0 | MSG090928955 | 0.977 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | ATP | 4.0 | MSG090928959 | 1.01 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | ATP | 8.0 | MSG090928963 | 1.1 | pmol/ug DNA |
LMFA01030159 | 11,14,17-eicosatrienoic acid | ATP | 20.0 | MSG090928967 | 0.887 | pmol/ug DNA |